Year |
Citation |
Score |
2012 |
Mamo A, Cavallone L, Tuzmen S, Chabot C, Ferrario C, Hassan S, Edgren H, Kallioniemi O, Aleynikova O, Przybytkowski E, Malcolm K, Mousses S, Tonin PN, Basik M. An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer. Oncogene. 31: 2090-100. PMID 21892209 DOI: 10.1038/Onc.2011.386 |
0.322 |
|
2011 |
Savas S, Azorsa DO, Jarjanazi H, Ibrahim-Zada I, Gonzales IM, Arora S, Henderson MC, Choi YH, Briollais L, Ozcelik H, Tuzmen S. NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells. Plos One. 6: e18306. PMID 21483694 DOI: 10.1371/Journal.Pone.0018306 |
0.557 |
|
2011 |
Basak AN, Tuzmen S. Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approach. Methods in Molecular Biology (Clifton, N.J.). 700: 291-307. PMID 21204041 DOI: 10.1007/978-1-61737-954-3_19 |
0.482 |
|
2008 |
Jarjanazi H, Kiefer J, Savas S, Briollais L, Tuzmen S, Pabalan N, Ibrahim-Zada I, Mousses S, Ozcelik H. Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine. Human Mutation. 29: 461-7. PMID 18330920 DOI: 10.1002/Humu.20732 |
0.561 |
|
2007 |
Kuuselo R, Savinainen K, Azorsa DO, Basu GD, Karhu R, Tuzmen S, Mousses S, Kallioniemi A. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification. Cancer Research. 67: 1943-9. PMID 17332321 DOI: 10.1158/0008-5472.CAN-06-3387 |
0.426 |
|
2006 |
Savas S, Tuzmen S, Ozcelik H. Human SNPs resulting in premature stop codons and protein truncation. Human Genomics. 2: 274-86. PMID 16595072 DOI: 10.1186/1479-7364-2-5-274 |
0.525 |
|
2004 |
Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S, Weaver D, Robbins C, Moses T, Allinen M, Hautaniemi S, Chen Y, Elkahloun A, Basik M, Bova GS, et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nature Genetics. 36: 979-83. PMID 15300251 DOI: 10.1038/Ng1408 |
0.553 |
|
Show low-probability matches. |